Chantelle Inguanti

Chantelle Inguanti

Details

Role Research Assistant
Research area Stem Cell Medicine
Chantelle Inguanti is a Research Assistant at the Murdoch Children's Research Institute, working with Professor Andrew Elefanty to investigate the differentiation of haematopoietic stem cells from human induced pluripotent stem cells. The ultimate aim being to generate functional blood stem cells in the laboratory that could be used in place of human bone marrow for the treatment of leukemia and other blood disorders.

Chantelle completed her Bachelor of Biomedicine at La Trobe University in 2021 before undertaking her honours year under the supervision of Dr Lisa Mielke based at the Olivia Newton-John Cancer Research Institute. Continuing on in Lisa Mielke's laboratory as a Research Assistant, Chantelle worked on characterising γδ T-IELs within the colon microenvironment to decipher their role as a potential therapeutic target for limiting Colorectal Cancer progression.
Chantelle Inguanti is a Research Assistant at the Murdoch Children's Research Institute, working with Professor Andrew Elefanty to investigate the differentiation of haematopoietic stem cells from human induced pluripotent stem cells. The ultimate aim...
Chantelle Inguanti is a Research Assistant at the Murdoch Children's Research Institute, working with Professor Andrew Elefanty to investigate the differentiation of haematopoietic stem cells from human induced pluripotent stem cells. The ultimate aim being to generate functional blood stem cells in the laboratory that could be used in place of human bone marrow for the treatment of leukemia and other blood disorders.

Chantelle completed her Bachelor of Biomedicine at La Trobe University in 2021 before undertaking her honours year under the supervision of Dr Lisa Mielke based at the Olivia Newton-John Cancer Research Institute. Continuing on in Lisa Mielke's laboratory as a Research Assistant, Chantelle worked on characterising γδ T-IELs within the colon microenvironment to decipher their role as a potential therapeutic target for limiting Colorectal Cancer progression.

Top Publications

  • Yakou, MH, Ghilas, S, Tran, K, Liao, Y, Afshar-Sterle, S, Kumari, A, Schmid, K, Dijkstra, C, Inguanti, C, Ostrouska, S, et al. TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma. Science Immunology 8(88) : eadf2163 2023
    view publication

Career information